|
SSR1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.055800E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.067650E-01 |
| Normal-vs-Stage2 |
2.838200E-01 |
| Normal-vs-Stage3 |
4.599600E-02 |
| Normal-vs-Stage4 |
7.054400E-02 |
| Stage1-vs-Stage2 |
8.415800E-01 |
| Stage1-vs-Stage3 |
4.147000E-01 |
| Stage1-vs-Stage4 |
5.169800E-01 |
| Stage2-vs-Stage3 |
7.708200E-01 |
| Stage2-vs-Stage4 |
8.725000E-01 |
| Stage3-vs-Stage4 |
8.781400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.548500E-02 |
| Normal-vs-AfricanAmerican |
2.1523999999995E-05 |
| Normal-vs-Asian |
3.553200E-01 |
| Caucasian-vs-AfricanAmerican |
2.755600E-04 |
| Caucasian-vs-Asian |
8.136800E-01 |
| AfricanAmerican-vs-Asian |
2.545600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.738190E-02 |
| Normal-vs-Female |
2.163800E-01 |
| Male-vs-Female |
2.256600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.104070E-02 |
| Normal-vs-Age(41-60Yrs) |
8.047700E-02 |
| Normal-vs-Age(61-80Yrs) |
7.050400E-02 |
| Normal-vs-Age(81-100Yrs) |
7.927800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.022600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.699650E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.483800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.970200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.129000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.818400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.076200E-01 |
| Normal-vs-Grade 2 |
3.399800E-01 |
| Normal-vs-Grade 3 |
1.752360E-02 |
| Normal-vs-Grade 4 |
1.564440E-02 |
| Grade 1-vs-Grade 2 |
8.683000E-01 |
| Grade 1-vs-Grade 3 |
5.736200E-01 |
| Grade 1-vs-Grade 4 |
4.454400E-01 |
| Grade 2-vs-Grade 3 |
8.810300E-02 |
| Grade 2-vs-Grade 4 |
7.946500E-02 |
| Grade 3-vs-Grade 4 |
5.909200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.389200E-01 |
| Normal-vs-ccB subtype |
6.963700E-02 |
| ccA subtype-vs-ccB subtype |
6.307800E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.881180E-01 |
| Normal-vs-N1 |
9.182600E-01 |
| N0-vs-N1 |
6.918000E-01 |
|
|
